Clinical trial
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of Neuromyelitis Optica Spectrum Disorder
NCT05566769 is registered in ClinicalTrials.gov with Ad scientiam as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Performance and Safety of a Digital Tool for Unsupervised Self-assessment of Neuromyelitis Optica Spectrum Disorder
- Lead sponsor
- Ad scientiam
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 3, 2023
- Completion date
- September 30, 2026
- Enrollment
- 103 (estimated)
- Sites
- 22
Conditions
As the registry lists them; a condition with its own page is linked.